Literature DB >> 11684564

Chronic caffeine consumption exacerbates hypertension in rats with polycystic kidney disease.

G A Tanner1, J A Tanner.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited disorder frequently associated with renal failure, hypertension, and other abnormalities. The present study determined whether chronic caffeine intake in an animal model of this disease would affect renal structure and function and blood pressure. Heterozygous male Han:Sprague-Dawley rats with ADPKD and normal littermates were provided with either tap water or solutions of caffeine to drink, starting at 1 month of age. When rats were aged 6 months, glomerular filtration rate (GFR) and mean arterial blood pressure (MAP) were measured under Inactin (Byk Gulden, Konstanz, Germany) anesthesia. Caffeine intake had no effect on GFR or cyst development in rats with PKD. MAP was greater in rats with PKD than normal rats and was increased more by caffeine. The hypertensive effect of chronic caffeine intake could not be ascribed to direct pressor effects of angiotensin II. Based on our finding that caffeine exacerbates hypertension in rats with PKD, it may be prudent for patients with ADPKD to limit coffee consumption to four or fewer cups of caffeinated coffee per day, pending studies of humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684564     DOI: 10.1053/ajkd.2001.28614

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

Review 1.  Determinants of renal disease variability in ADPKD.

Authors:  Peter C Harris; Sandro Rossetti
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

Review 2.  Methylxanthines and the kidney.

Authors:  Hartmut Osswald; Jürgen Schnermann
Journal:  Handb Exp Pharmacol       Date:  2011

3.  A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease.

Authors:  Irina Barash; Manish P Ponda; David S Goldfarb; Edward Y Skolnik
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 8.237

Review 4.  Caffeine in Kidney Stone Disease: Risk or Benefit?

Authors:  Paleerath Peerapen; Visith Thongboonkerd
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

5.  Antihypertensive effect of celery seed on rat blood pressure in chronic administration.

Authors:  Maryam Hassanpour Moghadam; Mohsen Imenshahidi; Seyed Ahmad Mohajeri
Journal:  J Med Food       Date:  2013-06-04       Impact factor: 2.786

Review 6.  The pathobiology of polycystic kidney disease from a metabolic viewpoint.

Authors:  Luis Fernando Menezes; Gregory G Germino
Journal:  Nat Rev Nephrol       Date:  2019-09-05       Impact factor: 28.314

7.  Caffeine intake by patients with autosomal dominant polycystic kidney disease.

Authors:  L C Vendramini; J L Nishiura; A C Baxmann; I P Heilberg
Journal:  Braz J Med Biol Res       Date:  2012-07-19       Impact factor: 2.590

8.  A review on renal toxicity profile of common abusive drugs.

Authors:  Varun Parkash Singh; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2013-07-30       Impact factor: 2.016

9.  Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort.

Authors:  Katelyn A McKenzie; Mirelle El Ters; Vicente E Torres; Peter C Harris; Arlene B Chapman; Michal Mrug; Frederic F Rahbari-Oskoui; Kyongtae Ty Bae; Douglas P Landsittel; William M Bennett; Alan S L Yu; Jonathan D Mahnken
Journal:  BMC Nephrol       Date:  2018-12-27       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.